Rydar Equities’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Rydar Equities's LLY Position: Q3 2026 in Review
Rydar Equities increased its Eli Lilly (LLY) stake by 13% in Q3 2026, buying an estimated $245K and bringing the position to 1,783 shares worth $2.12M. The position accounts for 1.09% of the portfolio, ranked #30.
Rydar Equities first reported a position in LLY in Q2 2025 and has held it in 6 quarters since. 904 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Rydar Equities held 1,783 shares of Eli Lilly worth $2.12M as of Q3 2026.
- Rydar Equities bought 208 Eli Lilly shares in Q3 2026, an estimated $245K.
- Eli Lilly made up 1.09% of Rydar Equities's portfolio in Q3 2026, its #30 holding.
- Rydar Equities first reported a position in Eli Lilly in Q2 2025 and has held it in 6 quarters since.
- 904 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Rydar Equities's 13F filing for Q3 2026, filed 13 Oct 2026.